Abstract
Biomaterials are widely used to produce devices for regenerative medicine. After its implantation, an interaction between the host immune system and the implanted biomaterial occurs, leading to biomaterial-specific cellular and tissue responses. These responses may include inflammatory, wound healing responses, immunological and foreign-body reactions, and even fibrous encapsulation of the implanted biomaterial device. In fact, the cellular and molecular events that regulate the success of the implant and tissue regeneration are played at the interface between the foreign body and the host inflammation, determined by innate and adaptive immune responses. This chapter focuses on host responses that must be taken into consideration in determining the biocompatibility of biomaterial devices when implanted in vivo of animal models.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anderson JM (2019) Biocompatibility and bioresponse to biomaterials. In: Atala A, Lanza R, Mikos AG, Nerem R (eds) Principles of regenerative medicine, 3rd edn. Elsevier, London, pp 675–694
Vasconcelos DP, Águas AP, Barbosa MA et al (2019) The inflammasome in host response to biomaterials : bridging inflammation and tissue regeneration. Acta Biomater 83:1–12
Christo SN, Diener KR, Bachhuka A et al (2015) Innate immunity and biomaterials at the nexus : friends or foes. Biomed Res Int 2015:342304
Saleh LS, Bryant SJ (2017) In vitro and in vivo models for assessing the host response to biomaterials. Drug Discov Today Dis Model 24:13–21
Costa-Pinto A, Santos TC, Neves NM et al (2016) Testing natural biomaterials in animal models. In: Neves NM, Reis RL (eds) Biomaterials from nature for advanced devices and therapies, 1st edn. Wiley, Hoboken, pp 562–579
Anderson JM (2001) Biological responses to materials. Annu Rev Mater Res 31:81–110
Sheikh Z, Brooks PJ, Barzilay O et al (2015) Macrophages, foreign body giant cells and their response to implantable biomaterials. Materials 8(9):5671–5701
Anderson JM, Rodriguez A, Chang DT (2008) Foreign body reaction to biomaterials. Semin Immunol 20(2):86–100
Salgado AJ, Coutinho OP, Reis RL et al (2007) In vivo response to starch-based scaffolds designed for bone tissue engineering applications. J Biomed Mater Res 80(4):983–989
Delves PJ, Martin SJ, Burton DR et al (2011) Roitt’s essential immunology, 12th edn. Wiley-Blackwell, Hoboken
Mariani E, Lisignoli G, Maria R et al (2019) Biomaterials: foreign bodies or tuners for the immune response? Int J Mol Sci 20(3):636
Santos TC, Reis RL, Marques AP (2016) Can host reaction animal models be used to predict and modulate skin regeneration? J Tissue Eng Regen Med 11(8):2295–2303
Major MR, Wong VW, Nelson ER et al (2015) The foreign body response: at the interface of surgery and bioengineering. Plast Reconstr Surg 135(5):1489–1498
Ma PX (2008) Biomimetic materials for tissue engineering. Adv Drug Deliv Rev 60(2):184–198
Hasirci V, Hasirci N (2018) Fundamentals of biomaterials. Springer, New York
Gretchen SS, Fetz AE, Radic MZ et al (2017) An overview of the role of neutrophils in innate immunity, inflammation and host-biomaterial integration. Regen Biomater 4(1):55–68
Weissman G, Smoles JE, Korchak HM (1980) Release of inflammatory mediators from stimulates neutrophils. N Engl J Med 303:27–34
Wilson CJ, Clegg RE, Ph D et al (2005) Mediation of biomaterial – cell interactions by adsorbed proteins: a review. Tissue Eng 11(1–2):1–18
Tang BL, Eaton JW (1993) Fibrin (ogen) mediates acute inflammatory responses to biomaterials. J Exp Med 178(6):2147–2156
Vroman L, Adams AL, Fischer GC et al (1980) Interaction of high molecular weight kininogen, factor XII, and fibrinogen in pPlasma at interfaces. Blood 55(1):156–159
Kim YK, Que R, Wang SW et al (2014) Modification of biomaterials with a self protein inhibts the macrophage response. Adv Healthc Mater 3(7):989–994
Milleret V, Buzzi S, Gehrig P et al (2015) Protein adsorption steers blood contact activation on engineered cobalt chromium alloy oxide layers. Acta Biomater 24:343–351
Markiewski MM, Nilsson B, Ekdahl KN et al (2007) Complement and coagulation: strangers or partners in crime? Trends Immunol 28(4):184–192
Jenney CR, Anderson JM (2000) Adsorbed IgG: a potent adhesive substrate for human macrophages. J Biomed Mater Res 50(3):281–290
Gorbet MB, Sefton MV (2004) Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 25(26):5681–5703
Ekdahl KN, Lambris JD, Elwing H et al (2011) Innate immunity activation on biomaterial surfaces: a mechanistic model and coping strategies. Adv Drug Deliv Rev 63(12):1042–1050
Chiumiento A, Lamponi S, Barbucci R (2007) Role of fibrinogen conformation in platelet activation. Biomacromolecules 8(2):523–531
Wu Y, Simonovsky FI, Ratner BD, Horbett TA (2005) The role of adsorbed fibrinogen in platelet adhesion to polyurethane surfaces: a comparison of surface hydrophobicity, protein adsorption, monoclonal antibody binding, and platelet adhesion. J Biomed Mater Res 74(4):722–738
Hong J, Ekdahl KN, Reynolds H et al (1999) A new in vitro model to study interaction between whole blood and biomaterials: studies of platelet and coagulation activation and the effect of aspirin. Biomaterials 20(7):603–611
Zhou G, Groth T (2018) Host responses to biomaterials and anti-inflammatory design — a brief review. Macromol Biosci 18(8):e1800112
Andersson J, Nilsson K, Lambris JD et al (2005) Binding of C3 fragments on top of adsorbed plasma proteins during complement activation on a model biomaterial surface. Biomaterials 26(13):1477–1485
Flick MJ, Du X, Witte DP et al (2004) Leukocyte engagement of fibrin (ogen) via the integrin receptor α M β 2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest 113(11):1596–1606
Nilsson B, Nilsson K, Eirik T et al (2007) The role of complement in biomaterial-induced inflammation. Mol Immunol 44(1–3):82–94
Szaba FM, Smiley ST (2002) Roles for thrombin and fibrin (ogen) in cytokune/chemokine production and macrophage adhesion in vivo. Blood 99(3):1053–1059
Li M, Peake PW, Charlesworth JA et al (2007) Complement activation contributes to leukocyte recruitment and neuropathic pain following peripheral nerve injury in rats. Eur J Neurosci 26(12):3486–3500
Hed J, Johansson M, Lindroth M (1984) Complement activation according to the alternate pathway by glass and plastic surfaces and its role in neutrophil adhesion. Immunol Lett 8(6):295–299
Sarma JV, Ward PA (2011) The complement system. Cell Tissue Res 343(1):227–235
Lhotta K, Wurzner R, Kronenberg F et al (1998) Rapid activation of the complement system by cuprophane depends on complement component C4. Kidney Int 53(4):1044–1051
Chenoweth DE (1987) Complement activation in extracorporeal circuits. Ann N Y Acad Sci 516:306–313
Becker EL (1972) The relationship of the chemotactic behavior of the complement-derived factors, C3a, C5a, and C567, and a bacterial chemotactic factor to their ability to activate the proesterase 1 of rabbit polymorphonuclear leukocytes. J Exp Med 135(2):376–387
McNally AK, Jones JA et al (2008) Vitronectin is a critical protein adhesion substrate for IL-4-induced foreign body giant cell formation. J Biomed Mater Res 86(2):535–543
Keselowsky BG, Bridges AW, Burns KL et al (2007) Role of plasma fibronectin in the foreign body response to biomaterials. Biomaterials 28(25):3626–3631
Shen M, Garcia I, Maier RV et al (2004) Effects of adsorbed proteins and surface chemistry on foreign body giant cell formation, tumor necrosis factor alpha release and procoagulant activity of monocytes. J Biomed Mater Res 70(4):533–541
Franz S, Rammelt S, Scharnweber D et al (2011) Biomaterials immune responses to implants-a review of the implications for the design of immunomodulatory biomaterials. Biomaterials 32(28):6692–6709
Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124(4):783–801
Bianchi ME (2007) DAMPs, PAMPs and alarmins : all we need to know about danger. J Leucoc Biol 81(1):1–5
Grandjean-laquerriere A, Tabary O, Jacquot J et al (2007) Involvement of toll-like receptor 4 in the inflammatory reaction induced by hydroxyapatite particles. Biomaterials 28(3):400–404
De Oliveira S, López-muñoz A, Candel S et al (2014) ATP modulates acute inflammation in vivo through dual oxidase 1 − derived H 2 O 2 production and NF- κ B activation. J Immunol 192(12):5710–5719
Lee J, Jackman JG, Kwun J et al (2017) Nucleic acid scavenging microfiber mesh inhibits trauma-induced inflammation and thrombosis. Biomaterials 120:94–102
Wright HL, Moots RJ, Bucknall RC et al (2010) Neutrophil function in inflammation and inflammatory diseases. Rheumatology 49(9):1618–1631
Labow RS, Meek E, Santerre JP (2001) Neutrophil-mediated biodegradation of medical implant materials. J Cell Physiol 186(1):95–103
Nimeri G, Ohman L, Elwing H et al (2002) The influence of plasma proteins and platelets on oxygen radical production and F-actin distribution in neutrophils adhering to polymer surfaces. Biomaterials 23(8):1785–1795
Nimeri G, Majeed M, Elwing H et al (2003) Oxygen radical production in neutrophils interacting with platelets and surface-immobilized plasma proteins : role of tyrosine phosphorylation. J Biomed Mater Res 67(2):439–447
Branzk N, Lubojemska A, Hardison SE et al (2015) Europe PMC funders group neutrophils sense microbial size and selectively release neutrophil extracellular traps in response to large pathogens. Nat Immunol 15(11):1017–1025
Hahn J, Schauer C, Czegley C et al (2018) Aggregated neutrophil extracellular traps resolve inflammation by proteolysis of cytokines and chemokines and protection from antiproteases. FASEB J 33(1):1401–1414
Yamashiro S, Kamohara H, Wang J et al (2001) Phenotypic and functional change of cytokine-activated neutrophils: inflammatory neutrophils are heterogeneous and enhance adaptive immune responses. J Leucoc Biol 69(5):698–704
Altieri DC, Mannucci PM, Capitanio AM (1986) Binding of fibrinogen to human monocytes. J Clin Invest 78(4):968–976
Mesure L, De Visscher G, Vranken I et al (2010) Gene expression study of monocytes/macrophages during early foreign body reaction and identification of potential precursors of myofibroblasts. PLoS One 5(9):e12949
Badylak SF, Gilbert TW (2008) Immune response to biologic scaffold materials. Semin Immunol 20(2):109–116
Lynn AD, Kyriakides TR, Bryant SJ (2009) Characterization of the in vitro macrophage response and in vivo host response to poly (ethylene glycol)-based hydrogels. J Biomed Mater Res Part A 93(3):941–953
Zhao Q, Topham N, Anderson JM (1991) Foreign-body giant cells and polyurethane biostability : in vivo correlation of cell adhesion and surface cracking. J Biomed Mater Res 25(2):177–183
Mantovani A, Vecchi A, Allavena P (2014) ScienceDirect pharmacological modulation of monocytes and macrophages. Curr Opin Pharmacol 17:38–44
Wynn TA, Ph D, Barron L, Ph D (2010) Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis 30(3):245–257
Taylor PR, Martinez-Pomares L, Stacey M et al (2005) Macrophage receptors and immune recognition. Annu Rev Immunol 23:901–944
Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8(12):958–969
Brodbeck WG, Macewan M, Colton E et al (2005) Lymphocytes and the foreign body response : lymphocyte enhancement of macrophage adhesion and fusion. J Biomed Mater Res A 74(2):222–229
Helming L, Gordon S (2007) Macrophage fusion induced by IL-4 alternative activation is a multistage process involving multiple target molecules. Eur J Immunol 37(1):33–42
Arpaia N, Green JA, Moltedo B et al (2015) A distinct function of regulatory t cells in tissue protection. Cell 162(5):1078–1089
Browder T, Folkman J, Pirie-shepherd S (2000) The hemostatic system as a regulator of angiogenesis. J Biol Chem 275(3):1521–1524
Ward WK (2008) A review of the foreign-body response to subcutaneously-implanted devices: the role of macrophages and cytokines in biofouling and fibrosis. J Diabetes Sci Technol 2(5):768–777
Ratner BD (2002) Reducing capsular thickness and enhancing angiogenesis around implant drug release systems. J Control Release 78(1–3):211–218
Diegelmann RF, Evans MC (2004) Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci 9:283–289
Rockey DC, Bell D, Hill JA (2015) Fibrosis—a common pathway to organ injury and failure. N Engl J Med 372(1):1138–1149
Van Zutphen LFM, Baumans V, Beynen AC (2001) Principles of laboratory animal science, revised edition, 1st edn. Elsevier, New York
Azab AK, Doviner V, Orkin B et al (2007) Biocompatibility evaluation of crosslinked chitosan hydrogels after subcutaneous and intraperitoneal implantation in the rat. J Biomed Mater Res A 83(2):414–422
De Souza R, Zahedi P, Allen CJ et al (2009) Biocompatibility of injectable chitosan-phopholipid implant systems. Biomaterials 30(23–24):3818–3824
Tomazic-Jezic VJ, Merritt K, Umbreit TH (2001) Significance of the type and the size of biomaterial particles on phagocytosis and tissue distribution. J Biomed Mater Res 55(4):523–529
Bajaj G, Van Alstine WG, Yeo Y (2012) Zwitterionic chitosan derivative, a new bBiocompatible pharmaceutical excipient, prevents endotoxin-mediated cytokine release. PLoS One 7(1):e30899
Lozano FS, García-Criado FJ, Fresnadillo MJ et al (2002) Systemic inflammatory response induced by dacron graft and modulation by antimicrobial agents: experimental study. J Surg Res 107(1):7–13
Busuttil SJ, Ploplis VA, Castellino FJ et al (2004) A central role for plasminogen in the inflammatory response to biomaterials. J Thromb Harmostasis 2(10):1798–1805
Schlosser M, Wilhelm L, Urban G et al (2002) Immunogenicity of polymeric implants: long-term antibody response against polyester (Dacron) following the implantation of vascular prostheses into LEW.1A rats. J Biomed Mater Res 61(3):450–457
Skokos EA, Charokopos A, Khan K et al (2011) Lack of TNF-α-induced MMP-9 production and abnormal E-cadherin redistribution associated with compromised fusion in MCP-1-null macrophages. Am J Pathol 178(5):2311–2321
Kyriakides TR, Foster MJ, Keeney GE et al (2004) The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation. Am J Pathol 165(2):2157–2166
Mendes JB, Campos PP, Ferreira MAND et al (2007) Host response to sponge implants differs between subcutaneous and intraperitoneal sites in mice. J Biomed Mater Res B Appl Biomater 83(2):408–415
King A, Sandler S, Andersson A (2001) The effect of host factors and capsule composition on the cellular overgrowth on implanted alginate capsules. J Biomed Mater Res 57(3):374–383
Rodriguez A, MacEwan SR, Meyerson H et al (2009) The foreign body reaction in T-cell-deficient mice. J Biomed Mater Res A 90(1):106–113
Yang J, Jao B, Mcnally AK et al (2014) In vivo quantitative and qualitative assessment of foreign body giant cell formation on biomaterials in mice deficient in natural killer lymphocyte subsets, mast cells, or the interleukin-4 receptorα and in severe combined immunodeficient mice. J Biomed Mater Res A 102(6):2017–2023
Avula MN, Rao AN, McGill LD et al (2014) Foreign body response to subcutaneous biomaterial implants in a mast cell-deficient Kitw-Sh murine model. Acta Biomater 10(5):1856–1863
Gonzalez R, Hill SJ, Mattar SG et al (2011) Absorbable versus nonabsorbable mesh repair of congenital diaphragmatic hernias in a growing animal model. J Laparoendosc Adv Surg Tech 21(5):449–454
Roth WJ, Kissinger CB, McCain RR et al (2013) Assessment of juvenile pigs to serve as human pediatric surrogates for preclinical formulation pharmacokinetic testing. AAPS J 15:763–774
Seaton M, Hocking A, Gibran NS (2015) Porcine models of cutaneous wound healing. ILAR J 56(1):127–138
Krause TJ, Robertson FM, Greco RS (1993) Measurement of intracellular hydrogen peroxide induced by biomaterials implanted in a rodent air pouch. J Biomed Mater Res 27(1):65–69
Hooper KA, Nickolas TL, Yurkow EJ et al (2000) Characterization of the inflammatory response to biomaterials using a rodent air pouch model. J Biomed Mater Res 50(3):365–374
Wooley PH, Morren R, Andary J et al (2002) Inflammatory responses to orthopaedic biomaterials in the murine air pouch. Biomaterials 23(2):517–526
Kao WJ, Lee D (2001) In vivo modulation of host response and macrophage behavior by polymer networks grafted with fibronectin-derived biomimetic oligopeptides: the role of RGD and PHSRN domains. Biomaterials 22(21):2901–2909
Brodbeck WG, Patel J, Voskerician G et al (2002) Biomaterial adherent macrophage apoptosis is increased by hydrophilic and anionic substrates in vivo. PNAS 99(16):10287–10292
Laschke MW, Haufel JM, Thorlacius H et al (2005) New experimental approach to study host tissue response to surgical mesh materials in vivo. J Biomed Mater Res A 74(4):696–704
Brodbeck WG, Voskerician G, Ziats NP et al (2003) In vivo leukocyte cytokine mRNA responses to biomaterials are dependent on surface chemistry. J Biomed Mater Res A 64(2):320–329
Pawlina W (2016) Histology – text and atlas, 7th edn. Wolters Kluwer Health, Philadelphia
Correia RC, Santos TC, Pirraco RP et al (2017) In vivo osteogenic differentiation of stem cells inside compartmentalized capsules loaded with co-cultured endothelial cells. Acta Biomater 15:483–494
Popa EG, Carvalho PP, Dias AF et al (2014) Evaluation of the in vitro and in vivo biocompatibility of carrageenan-based hydrogels. Soc Biomater 102(11):4087–4097
Marques AP, Reis RL, Hunt JA (2005) An in vivo study of the host response to starch-based polymers and composites subcutaneously implanted in rats. Macromol Biosci 5:775–785
Rodrigues MT, Gomes ME, Viegas CA et al (2011) Tissue-engineered constructs based on SPCL scaffolds cultured with goat marrow cells: functionality in femoral defects. J Tissue Eng Regen Med 5(1):41–49
Spiller KL, Wrona EA, Romero-Torres S et al (2016) Differential gene expression in human, murine, and cell line-derived macrophages upon polarization. Exp Cell Res 347(1):1–13
Siegers GM, Swamy M, Fernández-Malavé E et al (2007) Different composition of the human and the mouse γδ T cell receptor explains different phenotypes of CD3γ and CD3δ immunodeficiencies. J Exp Med 204(11):2537–2544
Mestas J, Hughes CCW (2004) Of mice and not men: differences between mouse and human immunology. J Immunol 172(5):2731–2738
Rodríguez E, Ip WH, Kolbe V et al (2017) Humanized mice reproduce acute and persistent human adenovirus infection. J Infect Dis 215(1):70–79
Jespersen H, Lindberg MF, Donia M et al (2017) Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model. Nat Commun 8:707
Rong Z, Wang M, Hu Z et al (2014) An effective approach to prevent immune rejection of human ESC-derived allografts. Cell Stem Cell 14(1):121–130
Nishimura T, Hu Y, Wu M et al (2012) Using chimeric mice with humanized livers to predict human drug metabolism and a drug-drug interaction. J Pharmacol Exp Ther 344(2):388–396
Walsh NC, Kenney LL, Jangalwe S et al (2017) Humanized mouse models of clinical disease. Annu Rev Pathol 12:187–215
Duchosal MA, Eming SA, McConahey PJ et al (1992) The hu-PBL-SCID mouse model. Long-term human serologic evolution associated with the xenogeneic transfer of human peripheral blood leukocytes into SCID mice. Cell Immunol 139(2):468–477
Greiner DL, Hesselton RA, Shultz LD (1998) SCID mouse models of human stem cell engraftment. Stem Cells 16(3):166–177
Legrand N, Weijer K, Spits H (2014) Experimental models to study development and function of the human immune system in vivo. J Immunol 176(4):2053–2058
McCune JM (1996) Development and applications of the SCID-hu mouse model. Semin Immunol 8(4):187–196
Denton PW, García JV (2011) Humanized mouse models of HIV infection. AIDS Rev 13(3):135–148
Shultz LD, Brehm MA, Garcia-Martinez JV et al (2012) Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol 12(11):786–798
Wege AK, Melkus MW, Denton PW et al (2008) Functional and phenotypic characterization of the humanized BLT mouse model. Curr Top Microbiol Immunol 324:149–165
Shultz LD, Schweitzer PA, Christianson SW et al (1995) Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 154(1):180–191
Shultz LD, Lyons BL, Burzenski LM et al (2005) Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemotopoietic stem cells. J Immunol 174(10):6477–6489
Wang RM, Johnson TD, He J et al (2017) Humanized mouse model for assessing the human immune respose to xenogeneic and allogeneic decellularized biomaterials. Biomaterials 129:98–110
He J, Rong Z, Fu X, Xu Y (2017) A safety checkpoint to eliminate cancer risk of the immune evasive cells derived from human embryonic stem cells. Stem Cells 35(5):1154–1161
Zhao T, Zhang Z, Westenskow PD et al (2015) Humanized mice reveal differential immunogenicity of cells derived from autologous induced pluripotent stem cells. Cell Stem Cell 17(3):353–359
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Frazão, L.P., Vieira de Castro, J., Neves, N.M. (2020). In Vivo Evaluation of the Biocompatibility of Biomaterial Device. In: Chun, H., Reis, R., Motta, A., Khang, G. (eds) Biomimicked Biomaterials. Advances in Experimental Medicine and Biology, vol 1250. Springer, Singapore. https://doi.org/10.1007/978-981-15-3262-7_8
Download citation
DOI: https://doi.org/10.1007/978-981-15-3262-7_8
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-3261-0
Online ISBN: 978-981-15-3262-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)